Week 11 Flashcards
what gets exposed when blood vessel is injured
collagen and thromboplastin
platelets release 5-hydroxytrptamine ofr
muscle contraction + vasoconstriction
extrinsic vs intrinsic pathway; which is first
extrinsic first and form early fibrin plug
intrinsic to amplify coagulation and make stable fibrin plug
what activates fibrinogen to fibrin
thrombin
antithomrobotic factors (prevent clot formation)
prostacyclin, NO, ADPase
heparan sulfate
protein C
where are platelets made
megakaryotcytes in bone marrow
what regulates platelet production in the marrow
thrombopoietin
what increased platelet production
IL6 (inflammation) and decreased platelet numbers
lifespan of platelet
7-10 days
where are platelets stored
spleen
2 types of granules in platelets (which is most abundant)
alpha granules (most abundant) and dense granules
dense granules in platelets contain
ADP, Ca2+, serotonin, polyphosphate
alpha granules in platelets contain
vWF, FV, fibrinogen, growth factors (FGF, VEGF, PDGF), adhesive glycoproteins
which granule in platelet has adhesive glycoproteins to help bind injury
alpha granules
platelet glycoproteins in alpha granules
GP Ib/IX binds vWF
GP Ia/IIa binds collagen
these 2 above are for initial signals
GPIIb/IIIa- binds fibrinogen or vWF (only after platelet activates it by plateRR) (stabilize plug- platelet aggregation)
healthy endothelium contains _____ to prevent platelet activation
NO, prostacyclin, ADPase
vWF and collagen are hidden
plateRR (release reaction) releases many things to help clot
ADP, serotonin, thromboxane A2, coagulation factors, Ca2+, polyphosphate
how to platelets get leukocyte to injury
express P selectin
1st step in intrinsic and extrinsic pathway and final common pathway
extrinsic: FVIIa and TF (aka TPL or thromboplastin)
intrinsic: HMW kinongen kallikrein with FXIIa to activate
final: FXa + FVa + Ca2+ –> activate thrombin
what factor stabilizes fibrin
XIIIa
what does kinin-kvllikrein system release
bradykinin (vasodilate, pain, muscle contract, permeability)
FXII in intrinsic pathway causes inflammation via
bradykinin release
C3 and C5 cleavage
thrombin and fibrin split products (clot left overs)
decrease clot formation by
down regulate platelet activation (prostacyclin, NO, ADPase)
down regulate coagulation cascade
destroy clots (fibrinolysis)
antithrombotic/ anticoagulation mechanisms (stop clotting)
- antithrombin via heparin expression
protein C + protein S = thrombomodulin
tissue factor pathway inhibitor (TFPI) via heparin
plasminogen –> plasmin
fibrinolysis
how does plasminogen become plasmin? how does it degrade fibrin? into what?
plasminogen into plasmin via tPA (tissue plasminogen activator) and its degrades fibers into d -dimers
how to stop plasminogen from turning into plasmin and causing fibrinolysis (this is if you want clots)
plasminogen activator inhibitors (PAIs) block tPA
prothrombin time (PT) vs activated partial thromboplastin time (aPTT)
- which is for extrinsic vs intrinsic pathway
PT= extrinsic
aPTT= intrinsic
hemophilia A vs B
deficiency in which factors
A= FVIII (8)
B=FIX (9)
both are x linked recessive + similar clinical presentation
whats more common, hemophilia A or B
A
hemophilia presentation
deep bleeds in soft tissue… cant clot
RBCs/ erythrocytes are made in _____ (lifespan of _____) and recycled in _____
Red blood cells are produced in the bone marrow and have a lifespan of about 120 days (because no nucleus) before being recycled in the liver and spleen.
hemoglobin binds oxygen with low or high oxygen concentrations?
- Hb binds to oxygen at high oxygen concentrations
- Oxygen dissociates from Hb at low oxygen
concentrations
RBCs bind CO2 with what enzyme and converts it into what
carbonic anhydrase enzyme and converts it into bicarbonate ions (HCO3-)
what are RBCs derived from
myeloid progenitor (pronormoblast)
myeloid progenitor (pronormoblast) divide to become RBC via what
GM-CSF and EPO (erythropoietin)
erythropoiesis
pronormoblast divide to make 16-32 RBC via EPO
low O2 or high O2 to make EPO
low oxygen to make EPO
high oxygen HIF (hypoxia inducible factor) degrades EPO